Dupont Capital Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Dupont Capital Management’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,332	Closed	-$8.33K	–	1386
2022 Q4	$8.33K	Hold	33,332	–	–	﹤0.01%	1159
2022 Q3	$2K	Hold	33,332	–	–	﹤0.01%	1420
2022 Q2	$3K	Hold	33,332	–	–	﹤0.01%	1513
2022 Q1	$7K	Hold	33,332	–	–	﹤0.01%	1569
2021 Q4	$20K	Hold	33,332	–	–	﹤0.01%	1539
2021 Q3	$19K	Hold	33,332	–	–	﹤0.01%	1551
2021 Q2	$32K	Buy	+33,332	New	+$31K	﹤0.01%	1535

Dupont Capital Management's EBACW Position: Q1 2023 in Review

Dupont Capital Management sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 33,332 shares — an estimated $8.33K sold.

Dupont Capital Management first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $32K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Dupont Capital Management reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Dupont Capital Management sold 33,332 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $8.33K.
Dupont Capital Management first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Dupont Capital Management's European Biotech Acquisition Corp. Warrant position peaked at $32K in Q2 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.